Eximis Surgical

Eximis Surgical is addressing a critical gap in minimally invasive laparoscopic and robotic surgery: the removal of tissue specimens. Currently, surgeons often must significantly enlarge small incisions to extract tissue, negating some benefits of the minimally invasive approach. Eximis is developing a proprietary, contained removal system designed to allow safe and efficient specimen extraction through the original small ports. This innovation targets a potential market of 2 million patients annually, aiming to reduce pain, shorten hospital stays, and accelerate recovery.

Proprietary device platform for fully contained, minimally invasive removal of tissue specimens during laparoscopic and robotic surgery, designed to prevent tissue spillage and eliminate the need to enlarge small incisions.

Competition includes existing specimen retrieval bags and manual morcellation techniques, which are lower cost but lack full containment or efficiency. The landscape also includes other companies developing contained extraction systems. Eximis must differentiate on ease of use, reliability, and robust clinical data demonstrating superior safety and procedural benefits.